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WILFRED E. WOOLDRIDGE, M.D.
The clinical evaluation of a fungicide is difficult. The tendency of fungous
organisms to remain viable but go into resting states confuses the term "cure".
With those problems in mind a project was designed to assay a new fungicide,
2-nitro-2-bromo-1-methoxy-1-phenylpropane. This compound shall henceforth
be known by its commercial designation, P-594.t
By the time that P-594 was brought to our attention the facts were already
established that oral toxicity of this material was negligible and that therapeutic
concentrations of the fungicide in a water soluble ointment base were not pri-
mary irritants for the skin of white rabbits (1). Moderate intraperitoneal toxicity
for white mice was noted, the LD50 range being 195 38 mg./kg. Also estab-
lished were the facts that this material showed in vitro fungistasis for T. men-
tagrophytes in a concentration of 1 mcg./ml. and for C. albicans in a concentra-
tion of 30 ,zg./ml.
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METHOD
A vanishing cream-type base containing 1% of P-594 was employed in the treatment of
patients presenting glabrous mycotic infections. In addition, and with the same material,
50 patients were patch tested for primary irritancy during the routine application of patch
tests as diagnostic procedures.
Cases of tinea capitis were purposely avoided in this report. Likewise no infections are
reported in the study except those confirmed by culture. No other treatment was used
simultaneously and the presence of secondary infection did not contraindicate use of the
fungicide. Some of the infections had resisted previous treatment.
RESULTS
Trichophyton rubrum (purpureum). Forty-eight cases of infection with this
organism were treated. No infections of the nails were included in this group.
The chief sites of infection were feet, crural areas and the hands. Two patients
showed multiple generalized lesions. Duration of the infections was from a few
weeks to several years and most of the patients had received previous treatment.
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The shortest treatment period of this group was three weeks and the longest
period thirteen weeks. As might be expected, the plantar and palmar lesions
cleared very slowly. Three patients of this group were not benefited by treat-
ment and in each case these were patients with either plantar or palmar lesions.
Trichophyton. mentagrophytes. Twenty-one cases of infection with this organ-
ism were treated. Most of these infections were subacute and involved the feet,
particularly the interdigital spaces. Response to treatment was usually prompt
and convincing.
Epidermophyton floccosum. Three cases of infection with this organism were
treated. All responded promptly.
Microsporum fulvum. Two cases of infection with this organism were treated.
Both responded promptly.
Candida (inonilia). Seven cases of infection of the glabrous skin with this
organism were treated. No nail, oral or vaginal infections are included in this
series. Lesions on the feet, in the crural areas, the inguinal folds and beneath
TABLE I
ORGANISM NO. OP CASES
RESULTS
Cured Improved Unimproved
T. rtibrum
T. mentagrophytes
E. floccosum
M.fulvum
Candida (no species)
48
21
3
2
7
33
20
3
2
5
12
1
0
0
1
3
0
0
0
1
Totals 81 63 14 4
the breasts cleared rapidly. One patient showed infection on the soles as well as
between the toes. The interdigital areas cleared satisfactorily but the plantar
lesions remained.
Controls. Four patients were treated by "paired comparison." These patients
showed symmetrical lesions of infection with T. rubrum. One side of the body was
treated with the fungicidal ointment and the other side with the ointment base.
This treatment was continued for a few weeks so that it became apparent in
each case that the fungicide-treated areas were improving and the remainder
were not. Three additional patients infected with T. rubrum were similarly
treated except that Asterol (diamthazole dihydrochloride) ointment was used as
the control. In all cases improvement was greater in the lesions treated with
P-594.
A synopsis of the results of treatment appears in Table I.
DISCUSSION
In no case treated with one per cent P-594 ointment was primary irritation
observed. In each reported case treatment was continued for a sufficient period
to allow the development of allergic reactions but none were seen. Aside from
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the cases reported a few patients were treated with an ointment of the same base
but containing two per cent P-594. This concentration was mildly irritating to
some patients with more acute lesions.
The term "cure" (Table I) is used oniy in a clinical sense. No attempt was
made to confirm the cure with cultures at the end of treatment. Even the mildest
medication will so often render a mycotic lesion temporarily "sterile" that the
clinical appearance of lesions was accepted as the best criterion of effective
therapy.
Glabrous infections with most of the dermatophytes are not therapeutic
problems. T. rubrum, however, is always difficult to eradicate. It is in this type
of infection that P-594 is considered of most value. Also of advantage is its low
irritancy and its freedom from causing allergic reactions. As this series is ex-
tended, cases of hypersensitivity will undoubtedly occur but it seems unlikely
that such reactions will be frequent.
In view of these results it is suggested that P-594 be tried in the treatment of
tinea capitis. It is also thought that a solution of P-594 might be beneficial in
the treatment of onychomycosis.
CONCLUSIONS
1. A new fungicide, P-594, is presented.
2. This compound possesses low toxicity, little irritancy, an apparent low
sensitizing index and a high degree of efficiency in the treatment of mycotic
lesions of the glabrous skin.
3. It is considered of particular value in the treatment of infections caused
by T. rubrum.
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